首页> 外文期刊>European Heart Journal >Atorvastatin treatment improves survival and effects of implanted mesenchymal stem cells in post-infarct swine hearts
【24h】

Atorvastatin treatment improves survival and effects of implanted mesenchymal stem cells in post-infarct swine hearts

机译:阿托伐他汀治疗可改善梗死后猪心脏的存活率和植入间充质干细胞的作用

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Aims To investigate whether Atorvastatin (Ator) treatment improves the cardiac micro-environment that facilitates survival and differentiation of bone-marrow-derived mesenchymal stem cells (MSCs) implanted in the post-infarct myocardium.
机译:目的探讨阿托伐他汀(Atorvastatin,Ator)治疗是否改善心脏微环境,从而促进植入心肌梗死后心肌的骨髓间充质干细胞(MSC)的存活和分化。

著录项

  • 来源
    《European Heart Journal》 |2008年第12期|p.1578-1590|共13页
  • 作者单位

    1Department of Cardiology, Fu Wai Hospital and Cardiovascular Institute, Peking Union Medical College and Chinese Academy of Medical Sciences, 167 BeiLiShi Rd, Beijing 100037, People's Republic of China 2Emergency Center of Heart, Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital University of Medical Sciences &

    Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing 100029, People's Republic of China 3The Center for Cardiovascular Biology and Atherosclerosis, Department of Internal Medicine, The University of Texas, Health Science Center at Houston, Medical School, Texas Heart Institute, Houston, TX, USA 4Department of Nuclear Medicine, Fu Wai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, People's Republic of China 5Department of Radiology, Fu Wai Hospital;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号